The NCRI Brain Group’s “Delivering precision medicine for glioma” Working Group sets out to achieve Priority 3 of the NCRI Brain Group Strategic Priorities: To develop an innovative research trial to improve outcomes for brain tumour patients with unmet needs. 

This Working Group will design a study for recurrent glioblastoma patients that will define the relative roles of surgery, radiotherapy, chemotherapy and palliative care and will consider innovative study design, tissue biobanking, tumour sequencing and combination therapies.

You can see the full list of strategic priorities for the NCRI Brain Group here. 

Working Group members